Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trial
- Resource Type
- Article
- Source
- In
Multiple Sclerosis and Related Disorders March 2016 6:66-72 - Subject
- Language
- ISSN
- 2211-0348